SCHEMBL1521211

SCHEMBL1521211

CCOC(=O)C1C(=O)COC1=O

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
HSD17B10 Q99714 2/20 0.40
TLR4 O00206 1/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
PPM1B O75688 1/20 0.37
PTPN1 P18031 1/20 0.37
PPP1CC P36873 1/20 0.37
TSHR P16473 1/20 0.36
ATM Q13315 1/20 0.35
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3003984 0.98 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDHSD17B10TLR4
SCHEMBL3010029 0.98 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDHSD17B10TLR4
SCHEMBL1521223 0.79 BRD4 (0.38) ALDH1A1KMT2APPM1BPTPN1PPP1CC
SCHEMBL7952616 0.77 KDM4E (0.32) ALDH1A1KDM4EMAPTPTPN1TSHR
SCHEMBL7953369 0.73 HSD17B10 (0.46) ALDH1A1KDM4EHSD17B10MAPTGAA
SCHEMBL5924227 0.72
SCHEMBL11622190 0.72 CYP1A2 (0.38) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL31110744 0.72 TDP2 (0.39) ALDH1A1KDM4EHSD17B10MAPTMEN1
SCHEMBL354474 0.71 ALDH1A1 (0.48) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL3196831 0.71 ALDH1A1 (0.56) ALDH1A1KDM4EHPGDHSD17B10TLR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2464636-B1 PROCESS FOR THE SYNTHESIS OF 2,4-DIOXOTETRAHYDROFURAN-3-CARBOXYLATES BAYER IP GMBH (DE) 2015-07-08 EP disclosed
US-8318955-B2 Process for preparing 2,4-dioxotetrahydrofuran-3-carboxylates BAYER CROPSCIENCE AG (DE) 2012-11-27 US disclosed
EP-2464636-A1 METHOD FOR PRODUCING 2,4-DIOXOTETRAHYDROFURANE-3-CARBOXYLATES Bayer CropScience AG (DE) 2012-06-20 EP disclosed
US-20110060147-A1 Process for preparing 2,4-dioxotetrahydrofuran-3-carboxylates BAYER CROPSCIENCE AG (DE) 2011-03-10 US disclosed
WO-2011018180-A1 METHOD FOR PRODUCING 2,4-DIOXOTETRAHYDROFURANE-3-CARBOXYLATES BAYER CROPSCIENCE AG (DE) 2011-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110060147-A1 Process for preparing 2,4-dioxotetrahydrofuran-3-carboxylates HDHD5, HACL2, IDUA ALDH1A1 44/4885KDM4E 3262/4885HPGD 315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.